![Antony D. Buss](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Antony D. Buss
Geen lopende functies
Profiel
Antony D.
Buss served as President & Chief Executive Officer at MerLion Pharmaceuticals Pte Ltd.
from 2002 to 2011.
Prior to that, he held Principal positions at Bayer Schering Pharma AG, GSK Plc, and Pfizer SACI.
Buss earned a doctorate degree from the University of Cambridge in 1981 and a graduate degree from the University of East Anglia in 1978.
Eerdere bekende functies van Antony D. Buss
Bedrijven | Functie | Einde |
---|---|---|
GSK PLC | Corporate Officer/Principal | - |
Pfizer SACI
![]() Pfizer SACI Medical/Nursing ServicesHealth Services Part of Pfizer Inc., Pfizer SACI is a company based in Buenos Aires, Argentina. | Corporate Officer/Principal | - |
Bayer Schering Pharma AG | Corporate Officer/Principal | - |
MerLion Pharmaceuticals Pte Ltd.
![]() MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Algemeen Directeur | - |
Opleiding van Antony D. Buss
University of Cambridge | Doctorate Degree |
University of East Anglia | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GSK PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Bayer Schering Pharma AG | Health Technology |
MerLion Pharmaceuticals Pte Ltd.
![]() MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
Pfizer SACI
![]() Pfizer SACI Medical/Nursing ServicesHealth Services Part of Pfizer Inc., Pfizer SACI is a company based in Buenos Aires, Argentina. | Health Services |